Day One Biopharmaceuticals (DAWN) Other Non Operating Income: 2023-2025
Historic Other Non Operating Income for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to -$34,000.
- Day One Biopharmaceuticals' Other Non Operating Income fell 102.84% to -$34,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$36,000, marking a year-over-year decrease of 103.11%. This contributed to the annual value of $1.2 million for FY2024, which is 3142.50% up from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Other Non Operating Income stood at -$34,000, which was down 78.95% from -$19,000 recorded in Q2 2025.
- Day One Biopharmaceuticals' 5-year Other Non Operating Income high stood at $1.2 million for Q3 2024, and its period low was -$34,000 during Q3 2025.
- Its 3-year average for Other Non Operating Income is $111,600, with a median of -$10,000 in 2024.
- Data for Day One Biopharmaceuticals' Other Non Operating Income shows a peak YoY increase of 40,000.00% (in 2024) and a maximum YoY decrease of 150.00% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Day One Biopharmaceuticals' Other Non Operating Income stood at -$18,000 in 2023, then skyrocketed by 322.22% to $40,000 in 2024, then crashed by 102.84% to -$34,000 in 2025.
- Its Other Non Operating Income stands at -$34,000 for Q3 2025, versus -$19,000 for Q2 2025 and -$23,000 for Q1 2025.